Peijie Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peijie Hu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Dingxin Zhang
Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publications- Haipeng Si
Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, China
3 shared publications Shangzhi Li
Department of Orthopedics, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China
3 shared publicationsWenpeng Xu
Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publicationsXiangyu Lin
Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publicationsYu Xu
Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Carboxymethyl cellulose potent hemostatic sponge constructed via freeze-substitution porogenation followed by fluorinated cinnamic acid modification
Hemostatic sponges are commonly fabricated via freeze-drying and lack active hemostatic regulation capabilities. This work describes a novel freeze-substitution (FS) porogenation strategy to prepare carboxymethyl cellulose (CMC) hemostatic sponges, which proves to be a facile and versatile alternative to freeze-drying for sponge construction. To impart robust aqueous structural stability and active hemostasis-stimulating properties, the FS-derived CMC sponges were subsequently grafted with fluorinated cinnamic acid (FCA) via thermo-assisted esterification. The as-prepared FCA/CMC sponges possess an ultralow density of ~0.038 g/cm3 and a very high porosity of ~92.5%, along with satisfactory compressive strength to well withstand all physiological blood pressure levels. In vitro rabbit whole blood tests and in vivo rat hepatic and femoral artery hemorrhage models demonstrate that FCA/CMC reduced hemostasis time by over 65.6% and blood loss by over 77.7%, and substantially outperformed fluorine-free CA/CMC and commercial gelatin sponges with good biocompatibility. Their superior efficacy originates from prominent fluid absorption, structural resilience, and adhesion of erythrocytes and platelets due to the synergistic effects of phenyl group and its fluorination in FCA moieties, with the 4-fluoro-substituted derivative exhibiting the optimal performance. Together, this work demonstrates that FS approach coupled with FCA modification represents a promising strategy for developing high-performance hemostatic sponges.
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCarboxymethyl cellulose potent hemostatic sponge constructed via freeze-substitution porogenation followed by fluorinated cinnamic acid modification
Hemostatic sponges are commonly fabricated via freeze-drying and lack active hemostatic regulation capabilities. This work describes a novel freeze-substitution (FS) porogenation strategy to prepare carboxymethyl cellulose (CMC) hemostatic sponges, which proves to be a facile and versatile alternative to freeze-drying for sponge construction. To impart robust aqueous structural stability and active hemostasis-stimulating properties, the FS-derived CMC sponges were subsequently grafted with fluorinated cinnamic acid (FCA) via thermo-assisted esterification. The as-prepared FCA/CMC sponges possess an ultralow density of ~0.038 g/cm3 and a very high porosity of ~92.5%, along with satisfactory compressive strength to well withstand all physiological blood pressure levels. In vitro rabbit whole blood tests and in vivo rat hepatic and femoral artery hemorrhage models demonstrate that FCA/CMC reduced hemostasis time by over 65.6% and blood loss by over 77.7%, and substantially outperformed fluorine-free CA/CMC and commercial gelatin sponges with good biocompatibility. Their superior efficacy originates from prominent fluid absorption, structural resilience, and adhesion of erythrocytes and platelets due to the synergistic effects of phenyl group and its fluorination in FCA moieties, with the 4-fluoro-substituted derivative exhibiting the optimal performance. Together, this work demonstrates that FS approach coupled with FCA modification represents a promising strategy for developing high-performance hemostatic sponges.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 97-116
Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis
Glucocorticoid-induced osteoporosis (GIOP) is a prevalent and serious side effect of long-term glucocorticoid therapy, characterized by elevated oxidative stress and profound suppression of bone formation. There is a lack of therapies that effectively target the underlying oxidative stress and impaired osteogenesis simultaneously. In this study, we aimed to identify novel therapeutic agents from a library of quinonoid compounds. Using a high-throughput screen with Runx2 promoter-luciferase reporter cells, we identified decylubiquinone (DUB) as a potent candidate that counteracted dexamethasone (Dex)-induced oxidative stress and osteogenic suppression in bone marrow mesenchymal stem cells (BMSCs). In a murine GIOP model, DUB administration significantly alleviated bone loss, reduced oxidative stress, and inhibited osteoblast apoptosis. Mechanistically, DUB restored the glucocorticoid-impaired CD39/CD73/adenosine (ADO) axis, thereby elevating extracellular ADO levels. ADO subsequently exerted dual protective effects: it attenuated oxidative stress and apoptosis induced by glucocorticoids, and it activated the adenosine A2b receptor (A2bR), triggering the downstream cAMP/PKA/CREB signaling cascade to drive osteogenic gene expression. Genetic knockdown of CD39, CD73, or A2bR abolished the beneficial effects of both DUB and exogenous ADO. Furthermore, we developed bone-targeted DUB-loaded liposomes (DUB@TLip), which markedly enhanced the in vivo therapeutic efficacy of DUB. In summary, our study not only identifies DUB as a promising anabolic agent against GIOP but also reveals a novel mechanistic link between purinergic signaling and bone redox homeostasis, highlighting the therapeutic potential of targeting the CD39/CD73/ADO axis for treating this and potentially other oxidative stress-associated skeletal disorders.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 97-116
Open AccessScreening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis
Glucocorticoid-induced osteoporosis (GIOP) is a prevalent and serious side effect of long-term glucocorticoid therapy, characterized by elevated oxidative stress and profound suppression of bone formation. There is a lack of therapies that effectively target the underlying oxidative stress and impaired osteogenesis simultaneously. In this study, we aimed to identify novel therapeutic agents from a library of quinonoid compounds. Using a high-throughput screen with Runx2 promoter-luciferase reporter cells, we identified decylubiquinone (DUB) as a potent candidate that counteracted dexamethasone (Dex)-induced oxidative stress and osteogenic suppression in bone marrow mesenchymal stem cells (BMSCs). In a murine GIOP model, DUB administration significantly alleviated bone loss, reduced oxidative stress, and inhibited osteoblast apoptosis. Mechanistically, DUB restored the glucocorticoid-impaired CD39/CD73/adenosine (ADO) axis, thereby elevating extracellular ADO levels. ADO subsequently exerted dual protective effects: it attenuated oxidative stress and apoptosis induced by glucocorticoids, and it activated the adenosine A2b receptor (A2bR), triggering the downstream cAMP/PKA/CREB signaling cascade to drive osteogenic gene expression. Genetic knockdown of CD39, CD73, or A2bR abolished the beneficial effects of both DUB and exogenous ADO. Furthermore, we developed bone-targeted DUB-loaded liposomes (DUB@TLip), which markedly enhanced the in vivo therapeutic efficacy of DUB. In summary, our study not only identifies DUB as a promising anabolic agent against GIOP but also reveals a novel mechanistic link between purinergic signaling and bone redox homeostasis, highlighting the therapeutic potential of targeting the CD39/CD73/ADO axis for treating this and potentially other oxidative stress-associated skeletal disorders.
- Open Access
- 4 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7774
Publisher Correction: CFTR mediates Cl- transport in osteocytes to sustain cell viability and skeletal homeostasis
- 4 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 7774
Open AccessPublisher Correction: CFTR mediates Cl- transport in osteocytes to sustain cell viability and skeletal homeostasis
- Open Access
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
CFTR mediates Cl- transport in osteocytes to sustain cell viability and skeletal homeostasis
Osteocytes are long-lived with underlying mechanisms largely unknown. Here, we report that osteocyte-specific knockout of cystic fibrosis transmembrane conductance regulator (CFTR) results in excessive osteocyte death, proinflammatory cytokine surge, osteoclast overactivation and bone formation impairment leading to bone loss in adult mice. Consistently in MLO‑Y4 osteocyte‑line, CFTR-knockout causes progressive cell death, which is reversed by CFTR overexpression or medium replenishment. A massive proinflammatory osteocyte secretome is evoked by CFTR-knockout, which deteriorates wild-type osteocytes, inhibits osteogenic differentiation, while robustly stimulates osteoclastogenic differentiation in vitro. Patch-clamp/Cl--imaging verifies CFTR to mediate Cl- transport in osteocytes, while Cl--deprivation mimics CFTR-knockout to trigger transcriptomic/proteomic changes, cell stress and death. Additionally, osteocyte CFTR is downregulated in aged human bones; local delivery of CFTR via adenovirus or a CFTR modulator increases viable osteocytes and bone mass in aged mice. Together, the present study reveals a direct role of CFTR-mediated Cl- transport in sustaining osteocyte viability and skeletal homeostasis.
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCFTR mediates Cl- transport in osteocytes to sustain cell viability and skeletal homeostasis
Osteocytes are long-lived with underlying mechanisms largely unknown. Here, we report that osteocyte-specific knockout of cystic fibrosis transmembrane conductance regulator (CFTR) results in excessive osteocyte death, proinflammatory cytokine surge, osteoclast overactivation and bone formation impairment leading to bone loss in adult mice. Consistently in MLO‑Y4 osteocyte‑line, CFTR-knockout causes progressive cell death, which is reversed by CFTR overexpression or medium replenishment. A massive proinflammatory osteocyte secretome is evoked by CFTR-knockout, which deteriorates wild-type osteocytes, inhibits osteogenic differentiation, while robustly stimulates osteoclastogenic differentiation in vitro. Patch-clamp/Cl--imaging verifies CFTR to mediate Cl- transport in osteocytes, while Cl--deprivation mimics CFTR-knockout to trigger transcriptomic/proteomic changes, cell stress and death. Additionally, osteocyte CFTR is downregulated in aged human bones; local delivery of CFTR via adenovirus or a CFTR modulator increases viable osteocytes and bone mass in aged mice. Together, the present study reveals a direct role of CFTR-mediated Cl- transport in sustaining osteocyte viability and skeletal homeostasis.
- Open Access
- 7 November 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-13
Pregnane X receptor protects against age-related bone loss in males via PI3K/Akt-mediated inhibition of apoptosis
The pregnane X receptor (Pxr) regulates metabolism and inflammation, but its roles in bone homeostasis remain elusive. This study demonstrates that Pxr deficiency in bones induces osteoporotic phenotypes, with reduced trabecular bone mass, impaired osteogenesis, increased inflammation, and apoptosis. RNA sequencing reveals downregulation of the PI3K/Akt signaling pathway in Pxr-deficient bones, a key pathway linked to cell survival and differentiation. In vitro, primary bone marrow mesenchymal stem cells (BMSCs) with Pxr deficiency exhibited inhibited antioxidant enzyme activity, elevated intracellular reactive oxygen species level, activated pro-inflammatory cytokines, suppressed PI3K/Akt pathway, enhanced apoptosis, and decreased osteogenic differentiation. Conversely, Pxr overexpression in BMSCs from aged mice restores PI3K/Akt activation, mitigates apoptosis, and rescues osteogenic differentiation, with these multidirectional beneficial effects abrogated by a PI3K/Akt inhibitor. Moreover, both genetical overexpression of Pxr and pharmacological activation of Pxr improve bone quality in aged mice. These findings identify Pxr as a key regulator of bone homeostasis via the PI3K/Akt pathway, suggesting Pxr as a potential treatment target for age-related bone loss.
- 7 November 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-13
Open AccessPregnane X receptor protects against age-related bone loss in males via PI3K/Akt-mediated inhibition of apoptosis
The pregnane X receptor (Pxr) regulates metabolism and inflammation, but its roles in bone homeostasis remain elusive. This study demonstrates that Pxr deficiency in bones induces osteoporotic phenotypes, with reduced trabecular bone mass, impaired osteogenesis, increased inflammation, and apoptosis. RNA sequencing reveals downregulation of the PI3K/Akt signaling pathway in Pxr-deficient bones, a key pathway linked to cell survival and differentiation. In vitro, primary bone marrow mesenchymal stem cells (BMSCs) with Pxr deficiency exhibited inhibited antioxidant enzyme activity, elevated intracellular reactive oxygen species level, activated pro-inflammatory cytokines, suppressed PI3K/Akt pathway, enhanced apoptosis, and decreased osteogenic differentiation. Conversely, Pxr overexpression in BMSCs from aged mice restores PI3K/Akt activation, mitigates apoptosis, and rescues osteogenic differentiation, with these multidirectional beneficial effects abrogated by a PI3K/Akt inhibitor. Moreover, both genetical overexpression of Pxr and pharmacological activation of Pxr improve bone quality in aged mice. These findings identify Pxr as a key regulator of bone homeostasis via the PI3K/Akt pathway, suggesting Pxr as a potential treatment target for age-related bone loss.
- Open Access
- 9 August 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 16 (6) , 101432
Menaquinone-7 alleviates mitochondrial dysfunction and senescence in senile osteoporosis by targeting the PINK1-mediated mitophagy via PXR/ERK/CREB signaling pathway
- 9 August 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 16 (6) , 101432
Open AccessMenaquinone-7 alleviates mitochondrial dysfunction and senescence in senile osteoporosis by targeting the PINK1-mediated mitophagy via PXR/ERK/CREB signaling pathway
- 1 June 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 2910-2915
Decoupling Modulation Strategy for Three-Level Four-Leg Inverters Based on Independent Control of Fourth Leg
Three-level four-Leg inverters can be used to supply high-power balanced, unbalanced and/or nonlinear loads. However, the addition of a fourth leg extends the voltage vectors from two- to three-dimensional space and increases the complexity of the neutral-point (NP) potential control. To solve the above problems, a decoupling modulation strategy, which separates the control of the fourth leg from that of the former three legs, is presented to simplify the selection of the modulation vectors, output symmetrical three-phase voltages, and get balanced NP potential. The switching states of the former three legs are established by applying the three-leg nearest-three-virtual-vector (NTV 2 ) modulation method to the four-leg topology. And the switching state of the fourth leg is selected to meet the requirements of power quality and capacitor voltage. The behaviors of the proposed strategy are verified by the simulation results.
- 1 June 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 2910-2915
Decoupling Modulation Strategy for Three-Level Four-Leg Inverters Based on Independent Control of Fourth Leg
Three-level four-Leg inverters can be used to supply high-power balanced, unbalanced and/or nonlinear loads. However, the addition of a fourth leg extends the voltage vectors from two- to three-dimensional space and increases the complexity of the neutral-point (NP) potential control. To solve the above problems, a decoupling modulation strategy, which separates the control of the fourth leg from that of the former three legs, is presented to simplify the selection of the modulation vectors, output symmetrical three-phase voltages, and get balanced NP potential. The switching states of the former three legs are established by applying the three-leg nearest-three-virtual-vector (NTV 2 ) modulation method to the four-leg topology. And the switching state of the fourth leg is selected to meet the requirements of power quality and capacitor voltage. The behaviors of the proposed strategy are verified by the simulation results.